The biological functions of NF-κB1 (p50) and its potential as an anti-cancer target

Current Cancer Drug Targets

Volumn 9, Issue 4, 2009, Pages 566-571

  Yu, Yonghui ^a   Wan, Yu ^a   Huang, Chuanshu ^b  

^a WUHAN UNIVERSITY   (China)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLICE INHIBITORY PROTEIN; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; HISTONE DEACETYLASE 1; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE 4; PROTEIN; PROTEIN P50;

APOPTOSIS; CARCINOGENESIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; DRUG TARGETING; HUMAN; IMMUNE RESPONSE; NONHUMAN; PROTEIN PHOSPHORYLATION; REVIEW;

APOPTOSIS; CELL CYCLE PROTEINS; CELL PROLIFERATION; DRUG DELIVERY SYSTEMS; HUMANS; INFLAMMATION; MODELS, BIOLOGICAL; NEOPLASMS; NF-KAPPA B P50 SUBUNIT; NUCLEAR PROTEINS;

EID: 67649364424     PISSN: 15680096     EISSN: None     Source Type: Journal    
DOI: 10.2174/156800909788486759     Document Type: Review

References (68)

1. Hoffmann, A.; Baltimore, D. Circuitry of nuclear factor kappaB signaling. Immunol. Rev. 2006, 210, 171-186.
2. Chariot, A. 20 years of NF-kappaB. Biochem. Pharmacol. 2006, 7, 1051-1053.
3. Lin, L.; DeMartino, G. N.; Greene, W. C. Cotranslational biogenesis of NF-kappaB p50 by the 26S proteasome. Cell 1998, 92, 819-828. (Pubitemid 28155320)
4. Perkins, N. D. Integrating cell-signalling pathways with NFkappaB and IKK function. Nat. Rev. Mol. Cell Biol. 2007, 8, 49-62. (Pubitemid 46012014)
5. Massoumi, R.; Chmielarska, K.; Hennecke, K.; Pfeifer, A.; Fassler, R. Cyld inhibits tumor cell proliferation by blocking Bcl-3-dependent NF-kappaB signaling. Cell 2006, 125, 665-677.
6. Nolan, G. P.; Fujita, T.; Bhatia, K.; Huppi, C.; Liou, H. C.; Scott, M. L.; Baltimore, D. The bcl-3 proto-oncogene encodes a nuclear I kappa B-like molecule that preferentially interacts with NF-kappa B p50 and p52 in a phosphorylation-dependent manner. Mol. Cell Biol. 1993, 13, 3557-3566. (Pubitemid 23157293)
7. Beg, A. A.; Baldwin, A. S., Jr. The I kappa B proteins: multifunctional regulators of Rel/NF-kappa B transcription factors. Genes Dev. 1993, 7, 2064-2070. (Pubitemid 2010879)
8. Baldwin, A. S. Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB. J. Clin. Invest. 2001, 107, 241-246. (Pubitemid 32157954)
9. Lang, V.; Janzen, J.; Fischer, G. Z.; Soneji, Y.; Beinke, S.; Salmeron, A.; Allen, H.; Hay, R. T.; Ben-Neriah, Y.; Ley, S. C. betaTrCP- mediated proteolysis of NF-kappaB1 p105 requires phosphorylation of p105 serines 927 and 932. Mol. Cell Biol. 2003, 23, 402-413. (Pubitemid 36008530)
10. Guan, H.; Hou, S.; Ricciardi, R. P. DNA binding of repressor nuclear factor-kappaB p50/p50 depends on phosphorylation of Ser337 by the protein kinase A catalytic subunit. J. Biol. Chem. 2005, 280, 9957-9962. (Pubitemid 40395844)
11. Zhong, H.; May, M. J.; Jimi, E.; Ghosh, S. The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1. Mol. Cell 2002, 9, 625-636. (Pubitemid 34273792)
12. Blank, V.; Kourilsky, P.; Israel, A. Cytoplasmic retention, DNA binding and processing of the NF-kappa B p50 precursor are controlled by a small region in its C-terminus. EMBO J. 1991, 10, 4159-4167. (Pubitemid 21905448)
13. Hou, S.; Guan, H.; Ricciardi, R. P. Phosphorylation of serine 337 of NF-kappaB p50 is critical for DNA binding. J. Biol. Chem. 2003, 278, 45994-45998. (Pubitemid 37432747)
14. Song, L.; Li, J.; Zhang, D.; Liu, Z. G.; Ye, J.; Zhan, Q.; Shen, H. M.; Whiteman, M.; Huang, C. IKKbeta programs to turn on the GADD45alpha-MKK4-JNK apoptotic cascade specifically via p50 NF-kappaB in arsenite response. J. Cell Biol. 2006, 175, 607-617. (Pubitemid 44790614)
15. Takekawa, M.; Saito, H. A family of stress-inducible GADD45-like proteins mediate activation of the stress-responsive MTK1/MEKK4 MAPKKK. Cell 1998, 95, 521-530. (Pubitemid 28533308)
16. Kovalsky, O.; Lung, F. D.; Roller, P. P.; Fornace, A. J., Jr. Oligomerization of human Gadd45a protein. J. Biol. Chem. 2002, 276, 39330-39339. (Pubitemid 37371310)
17. Mita, H.; Tsutsui, J.; Takekawa, M.; Witten, E. A.; Saito, H. Regulation of MTK1/MEKK4 kinase activity by its N-terminal autoinhibitory domain and GADD45 binding. Mol. Cell Biol. 2002, 22, 4544-4555. (Pubitemid 34620392)
18. Grumont, R. J.; Rourke, I. J.; O'Reilly, L. A.; Strasser, A.; Miyake, K.; Sha, W.; Gerondakis, S. B lymphocytes differentially use the Rel and nuclear factor kappaB1 (NF-kappaB1) transcription factors to regulate cell cycle progression and apoptosis in quiescent and mitogen-activated cells. J. Exp. Med. 1998, 187, 663-674. (Pubitemid 28115182)
19. Gerwins, P.; Blank, J. L.; Johnson, G. L. Cloning of a novel mitogen- activated protein kinase kinase kinase, MEKK4, that selectively regulates the c-Jun amino terminal kinase pathway. J. Biol. Chem. 1997, 272, 8288-8295. (Pubitemid 27147785)
20. Tournier, C.; Hess, P.; Yang, D. D.; Xu, J.; Turner, T. K.; Nimnual, A.; Bar-Sagi, D.; Jones, S. N.; Flavell, R. A.; Davis, R. J. Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway. Science 2000, 288, 870-874. (Pubitemid 30257738)
21. Yin, F.; Bruemmer, D.; Blaschke, F.; Hsueh, W. A.; Law, R. E.; Herle, A. J. Signaling pathways involved in induction of GADD45 gene expression and apoptosis by troglitazone in human MCF-7 breast carcinoma cells. Oncogene 2004, 23, 4614-4623. (Pubitemid 38850409)
22. Zhang, D.; Song, L.; Li, J.; Wu, K.; Huang, C. Coordination of JNK1 and JNK2 is critical for GADD45alpha induction and its mediated cell apoptosis in arsenite responses. J. Biol. Chem. 2006, 281, 34113-34123. (Pubitemid 46036620)
23. de Martin, R.; Schmid, J. A.; Hofer-Warbinek, R. The NF-kappaB/Rel family of transcription factors in oncogenic transformation and apoptosis. Mutat. Res. 1999, 437, 231-243.
24. Barkett, M.; Gilmore, T. D. Control of apoptosis by Rel/NF-kappaB transcription factors. Oncogene 1999, 18, 6910-6924.
25. Xie, D. H.; Tang, X. D.; Xia, S. J.; Tan, J. M.; Wang, X. H.; Cai, Y. Expression of NF-kappa B in human bladder cancer and its clinical significance. Ai Zheng 2002, 21, 663-667.
26. Zen, K.; Karsan, A.; Stempien-Otero, A.; Yee, E.; Tupper, J.; Li, X.; Eunson, T.; Kay, M. A.; Wilson, C. B.; Winn, R. K.; Harlan, J. M. NF-kappaB activation is required for human endothelial survival during exposure to tumor necrosis factor-alpha but not to interleukin-1beta or lipopolysaccharide. J. Biol. Chem. 1999, 274, 28808-28815. (Pubitemid 129504760)
27. Sumitomo, M.; Tachibana, M.; Nakashima, J.; Murai, M.; Miyajima, A.; Kimura, F.; Hayakawa, M.; Nakamura, H. An essential role for nuclear factor kappa B in preventing TNF-alpha-induced cell death in prostate cancer cells. J. Urol. 1999, 161, 674-679.
28. McDade, T. P.; Perugini, R. A.; Vittimberga, F. J., Jr.; Carrigan, R. C.; Callery, M. P. Salicylates inhibit NF-kappaB activation and enhance TNF-alpha-induced apoptosis in human pancreatic cancer cells. J. Surg. Res. 1999, 83, 56-61. (Pubitemid 29394107)
29. Zhou, D.; Yu, T.; Chen, G.; Brown, S. A.; Yu, Z.; Mattson, M. P.; Thompson, J. S. Effects of NF-kappaB1 (p50) targeted gene disruption on ionizing radiation-induced NF-kappaB activation and TNFalpha, IL-1alpha, IL-1beta and IL-6 mRNA expression in vivo. Int. J. Radiat. Biol. 2001, 77, 763-772. (Pubitemid 32625544)
30. Glauert, H. P.; Tharappel, J. C.; Banerjee, S.; Chan, L. S.; Kania-Korwel, I.; Lehmler, H. J.; Lee, E. Y.; Robertson, L. W.; Spear, B. T. Inhibition of the promotion of hepatocarcinogenesis by 2,2′,4,4′,5, 5′-hexachlorobiphenyl (PCB-153) by the deletion of the p50 subunit of NF-kappaB in mice. Toxicol. Appl. Pharmacol. 2008, 232, 302-308.
31. Cahir-McFarland, E. D.; Davidson, D. M.; Schauer, S. L.; Duong, J.; Kieff, E. NF-kappa B inhibition causes spontaneous apoptosis in Epstein-Barr virus-transformed lymphoblastoid cells. Proc. Natl. Acad. Sci. USA 2000, 97, 6055-6060. (Pubitemid 30367522)
32. Bernal-Mizrachi, L.; Lovly, C. M.; Ratner, L. The role of NF- {kappa}B-1 and NF-{kappa}B-2-mediated resistance to apoptosis in lymphomas. Proc. Natl. Acad. Sci. USA 2006, 103, 9220-9225. (Pubitemid 43902559)
33. O'Neil, B. H.; Buzkova, P.; Farrah, H.; Kashatus, D.; Sanoff, H.; Goldberg, R. M.; Baldwin, A. S.; Funkhouser, W. K. Expression of nuclear factor-kappaB family proteins in hepatocellular carcinomas. Oncology 2007, 72, 97-104. (Pubitemid 350249136)
34. Lopez, A. F.; Sanderson, C. J.; Gamble, J. R.; Campbell, H. D.; Young, I. G.; Vadas, M. A. Recombinant human interleukin 5 is a selective activator of human eosinophil function. J. Exp. Med. 1988, 167, 219-224. (Pubitemid 18093705)
35. Yang, L.; Cohn, L.; Zhang, D. H.; Homer, R.; Ray, A.; Ray, P. Essential role of nuclear factor kappaB in the induction of eosinophilia in allergic airway inflammation. J. Exp. Med. 1998, 188, 1739-1750. (Pubitemid 28516118)
36. Yamaguchi, Y.; Suda, T.; Suda, J.; Eguchi, M.; Miura, Y.; Harada, N.; Tominaga, A.; Takatsu, K. Purified interleukin 5 supports the terminal differentiation and proliferation of murine eosinophilic precursors. J. Exp. Med. 1988, 167, 43-56. (Pubitemid 18093692)
37. Snapper, C. M.; Zelazowski, P.; Rosas, F. R.; Kehry, M. R.; Tian, M.; Baltimore, D.; Sha, W. C. B cells from p50/NF-kappa B knockout mice have selective defects in proliferation, differentiation, germ-line CH transcription, and Ig class switching. J. Immunol. 1996, 156, 183-191. (Pubitemid 26006962)
38. Pelletier, M.; Girard, D. Differential effects of IL-15 and IL-21 in myeloid (CD11b+) and lymphoid (CD11b-) bone marrow cells. J. Immunol. 2006, 177, 100-108. (Pubitemid 43939121)
39. DeAngelis, R. A.; Kovalovich, K.; Cressman, D. E.; Taub, R. Normal liver regeneration in p50/nuclear factor kappaB1 knockout mice. Hepatology 2001, 33, 915-924. (Pubitemid 32246641)
40. Artis, D.; Kane, C. M.; Fiore, J.; Zaph, C.; Shapira, S.; Joyce, K.; Macdonald, A.; Hunter, C.; Scott, P.; Pearce, E. J. Dendritic cell-intrinsic expression of NF-kappa B1 is required to promote optimal Th2 cell differentiation. J. Immunol. 2005, 174, 7154-7159. (Pubitemid 40705682)
41. Schafer, R.; Hartig, R.; Sedehizade, F.; Welte, T.; Reiser, G. Adenine nucleotides inhibit proliferation of the human lung adenocarcinoma cell line LXF-289 by activation of nuclear factor kappaB1 and mitogen-activated protein kinase pathways. FEBS J. 2006, 273, 3756-3767. (Pubitemid 44166656)
42. Guttridge, D. C.; Albanese, C.; Reuther, J. Y.; Pestell, R. G.; Baldwin, A. S., Jr. NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1. Mol. Cell Biol. 1999, 19, 5785-5799. (Pubitemid 29339933)
43. Hinz, M.; Krappmann, D.; Eichten, A.; Heder, A.; Scheidereit, C.; Strauss, M. NF-kappaB function in growth control: regulation of cyclin D1 expression and G0/G1-to-S-phase transition. Mol. Cell Biol.1999, 19, 2690-2698. (Pubitemid 29144513)
44. Shukla, S.; Maclennan, G. T.; Marengo, S. R.; Resnick, M. I.; Gupta, S. Constitutive activation of PI3 K-Akt and NF-kappaB during prostate cancer progression in autochthonous transgenic mouse model. Prostate 2005, 64, 224-239. (Pubitemid 40980864)
45. Lu, Z.; Lee, E. Y.; Robertson, L. W.; Glauert, H. P.; Spear, B. T. Effect of 2,2',4,4',5,5'-hexachlorobiphenyl (PCB-153) on hepatocyte proliferation and apoptosis in mice deficient in the p50 subunit of the transcription factor NF-kappaB. Toxicol. Sci. 2004, 81, 35-42. (Pubitemid 39199861)
46. Lin, S. C.; Liu, C. J.; Yeh, W. I.; Lui, M. T.; Chang, K. W.; Chang, C. S. Functional polymorphism in NFKB1 promoter is related to the risks of oral squamous cell carcinoma occurring on older male areca (betel) chewers. Cancer Lett. 2006, 243, 47-54. (Pubitemid 44508646)
47. Balkwill, F.; Mantovani, A. Inflammation and cancer: back to Virchow? Lancet 2001, 357, 539-545.
48. Li, Y.; Ahmed, F.; Ali, S.; Philip, P. A.; Kucuk, O.; Sarkar, F. H. Inactivation of nuclear factor kappaB by soy isoflavone genistein contributes to increased apoptosis induced by chemotherapeutic agents in human cancer cells. Cancer Res. 2005, 65, 6934-6942. (Pubitemid 41060733)
49. Coussens, L. M.; Werb, Z. Inflammation and cancer. Nature 2002, 420, 860-867.
50. Peebles, K. A.; Lee, J. M.; Mao, J. T.; Hazra, S.; Reckamp, K. L.; Krysan, K.; Dohadwala, M.; Heinrich, E. L.; Walser, T. C.; Cui, X.; Baratelli, F. E.; Garon, E.; Sharma, S.; Dubinett, S. M. Inflammation and lung carcinogenesis: applying findings in prevention and treatment. Expert Rev. Anticancer Ther. 2007, 7, 1405-1421. (Pubitemid 351826907)
51. Ishikawa, H.; Claudio, E.; Dambach, D.; Raventos-Suarez, C.; Ryan, C.; Bravo, R. Chronic inflammation and susceptibility to bacterial infections in mice lacking the polypeptide (p)105 precursor (NF-kappaB1) but expressing p50. J. Exp. Med. 1998, 187, 985-996. (Pubitemid 28176399)
52. Kato, A.; Edwards, M. J.; Lentsch, A. B. Gene deletion of NF-kappa B p50 does not alter the hepatic inflammatory response to ischemia/reperfusion. J. Hepatol. 2002, 37, 48-55. (Pubitemid 34713054)
53. Wessells, J.; Baer, M.; Young, H. A.; Claudio, E.; Brown, K.; Siebenlist, U.; Johnson, P. F. BCL-3 and NF-kappaB p50 attenuate lipopolysaccharide-induced inflammatory responses in macrophages. J. Biol. Chem. 2004, 279, 49995-50003. (Pubitemid 39577809)
54. Cao, S.; Zhang, X.; Edwards, J. P.; Mosser, D. M. NF-kappaB1 (p50) homodimers differentially regulate pro- and antiinflammatory cytokines in macrophages. J. Biol. Chem. 2006, 281, 26041-26050. (Pubitemid 44401810)
55. Oakley, F.; Mann, J.; Nailard, S.; Smart, D. E.; Mungalsingh, N.; Constandinou, C.; Ali, S.; Wilson, S. J.; Millward-Sadler, H.; Iredale, J. P.; Mann, D. A. Nuclear factor-kappaB1 (p50) limits the inflammatory and fibrogenic responses to chronic injury. Am. J. Pathol. 2005, 166, 695-708. (Pubitemid 40315627)
56. Greten, F. R.; Eckmann, L.; Greten, T. F.; Park, J. M.; Li, Z. W.; Egan, L. J.; Kagnoff, M. F.; Karin, M. IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 2004, 118, 285-296. (Pubitemid 39061110)
57. Lerebours, F.; Vacher, S.; Andrieu, C.; Espie, M.; Marty, M.; Lidereau, R.; Bieche, I. NF-kappa B genes have a major role in inflammatory breast cancer. BMC Cancer 2008, 8, 41.
58. Pikarsky, E.; Porat, R. M.; Stein, I.; Abramovitch, R.; Amit, S.; Kasem, S.; Gutkovich-Pyest, E.; Urieli-Shoval, S.; Galun, E.; Ben-Neriah, Y. NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature 2004, 431, 461-466. (Pubitemid 39329586)
59. Wang, Z. P.; Cai, S. X.; Liu, D. B.; Xu, X.; Liang, H. P. Antiinflammatory effects of a novel peptide designed to bind with NFkappaB p50 subunit. Acta. Pharmacol. Sin. 2006, 27, 1474-1478. (Pubitemid 44630316)
60. Mantovani, A.; Bottazzi, B.; Colotta, F.; Sozzani, S.; Ruco, L. The origin and function of tumor-associated macrophages. Immunol. Today 1992, 13, 265-270.
61. Mantovani, A.; Sozzani, S.; Locati, M.; Allavena, P.; Sica, A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 2002, 23, 549-555. (Pubitemid 35223554)
62. Sica, A.; Saccani, A.; Bottazzi, B.; Polentarutti, N.; Vecchi, A.; van Damme, J.; Mantovani, A. Autocrine production of IL-10 mediates defective IL-12 production and NF-kappa B activation in tumor-associated macrophages. J. Immunol. 2000, 164, 762-767. (Pubitemid 30043699)
63. Saccani, A.; Schioppa, T.; Porta, C.; Biswas, S. K.; Nebuloni, M.; Vago, L.; Bottazzi, B.; Colombo, M. P.; Mantovani, A.; Sica, A. p50 nuclear factor-kappaB overexpression in tumor-associated macrophages inhibits M1 inflammatory responses and antitumor resistance. Cancer Res. 2006, 66, 11432-11440. (Pubitemid 46009975)
64. Lin, S. C.; Lu, S. Y.; Lee, S. Y.; Lin, C. Y.; Chen, C. H.; Chang, K. W. Areca (betel) nut extract activates mitogen-activated protein kinases and NF-kappaB in oral keratinocytes. Int. J. Cancer 2005, 116, 526-535. (Pubitemid 41099188)
65. Kurland, J. F.; Kodym, R.; Story, M. D.; Spurgers, K. B.; McDonnell, T. J.; Meyn, R. E. NF-kappaB1 (p50) homodimers contribute to transcription of the bcl-2 oncogene. J. Biol. Chem. 2001, 276, 45380-45386. (Pubitemid 37391335)
66. Thornburg, N. J.; Pathmanathan, R.; Raab-Traub, N. Activation of nuclear factor-kappaB p50 homodimer/Bcl-3 complexes in nasopharyngeal carcinoma. Cancer Res. 2003, 63, 8293-8301. (Pubitemid 37549481)
67. Mukhopadhyay, T.; Roth, J. A.; Maxwell, S. A. Altered expression of the p50 subunit of the NF-kappa B transcription factor complex in non-small cell lung carcinoma. Oncogene 1995, 11, 999-1003.
68. Budunova, I. V.; Perez, P.; Vaden, V. R.; Spiegelman, V. S.; Slaga, T. J.; Jorcano, J. L. Increased expression of p50-NF-kappaB and constitutive activation of NF-kappaB transcription factors during mouse skin carcinogenesis. Oncogene 1999, 18, 7423-7431. (Pubitemid 30035043)